Accuray releases PlanTouch integrated software application in radiation oncology

NewsGuard 100/100 Score

Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the release of PlanTouch™, the first commercially available, fully integrated software application in radiation oncology that allows physicians to remotely review and approve patients' radiation treatment plans on the iPad. The PlanTouch software, developed in partnership with MIM Software Inc., Cleveland, Ohio, frees physicians using the CyberKnife® Robotic Radiosurgery System from work stations and provides them with increased collaboration, mobility, flexibility and convenience in delivering high-quality patient care. PlanTouch has received 510(k) clearance from the U.S. Food & Drug Administration (FDA).

PlanTouch's interface is fully integrated with the CyberKnife System's data management and planning software. Physicians can now review dose volume histograms, isodose curves, contours, and images and approve treatment plans directly from their iPads. This new mobile solution can enable improved collaboration between the radiation oncologist and referring physicians, such as thoracic surgeons, urologists and neurosurgeons. Physicians are no longer tied to planning workstations, but instead can access treatment plans remotely, wherever and whenever they need to, ensuring a seamless and efficient workflow. The ability not only to review, but also to approve a treatment plan is a function not available with any other tablet-based radiation oncology application on the market today.

"I am confident that PlanTouch will make our department more efficient by allowing us to speed up the time between consult, planning and initiation of treatment, which will, in turn, enable us to treat more patients," said Donald B. Fuller, M.D., radiation oncologist, CyberKnife Centers of San Diego. "The technology also has the potential to facilitate and improve timely communication about a patient's treatment plan among all treating physicians, helping us ensure that patients receive the best possible cancer care."

Unlike previously developed radiation treatment software, Accuray's PlanTouch is specifically designed for use on the iPad. For example, treatment planning displays are designed and formatted specifically for the iPad's smaller screen and can be manipulated using the iPad's touch screen capabilities. In addition, protections are in place to safeguard patients personal and health information and to ensure that physicians are accessing and analyzing the correct treatment plan for each patient.

"At Accuray, we continue to supply our physicians and patients with innovative, cutting-edge treatment solutions," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "The healthcare field is constantly evolving and mobility is more important than ever before. With PlanTouch, we are putting the power of the CyberKnife System's treatment planning technology onto the iPad and into the hands of treating physicians. The result is an application that meets an evolving need in radiation oncology and demonstrates our continued commitment to breaking new ground in the delivery of better, faster and more accurate cancer care."

Users can now purchase a software license upgrade for their CyberKnife Systems and download the app through the Apple® App Store™ to enable PlanTouch.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI chatbot offers accurate answers to radiation oncology queries